- Home
- EQR vs LH Comparison
EQR vs LH Comparison
Compare EQR & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQR | LH |
|---|---|---|
| Founded | 1993 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 22.1B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | EQR | LH |
|---|---|---|
| Price | $61.50 | $258.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 13 |
| Target Price | $70.00 | ★ $299.00 |
| AVG Volume (30 Days) | ★ 2.1M | 952.3K |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | ★ 4.54% | 1.11% |
| EPS Growth | 24.49 | ★ 98.36 |
| EPS | 3.03 | ★ 10.19 |
| Revenue | $3,078,827,000.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $5.06 | $10.82 |
| Revenue Next Year | $3.55 | $4.44 |
| P/E Ratio | ★ $20.13 | $25.37 |
| Revenue Growth | 4.69 | ★ 8.28 |
| 52 Week Low | $58.38 | $209.38 |
| 52 Week High | $75.86 | $293.72 |
Technical Indicators
Market Signals| Indicator | EQR | LH |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 41.12 |
| Support Level | $61.02 | $264.66 |
| Resistance Level | $62.42 | $272.82 |
| Average True Range (ATR) | 0.90 | 5.02 |
| MACD | 0.26 | -0.05 |
| Stochastic Oscillator | 62.17 | 4.62 |
Price Performance
Historical ComparisonAbout EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.